Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.95 SEK | -1.41% | -9.12% | +86.00% |
27/05 | Sweden’s IRLAB Therapeutics Names New CEO | MT |
27/05 | IRLAB Therapeutics AB Announces CEO Changes, Effective from August 1, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+86.00% | 69.63M | |
+47.11% | 765B | |
-6.81% | 354B | |
+19.10% | 331B | |
+8.51% | 299B | |
+18.77% | 248B | |
-1.84% | 219B | |
+11.08% | 216B | |
+4.91% | 164B | |
-2.66% | 162B |
- Stock Market
- Equities
- IRLAB A Stock
- News IRLAB Therapeutics AB
- IRLAB Therapeutics AB Appoints Martin Nicklasson as New Director